Nathalia Mayag Medina joins Neuro-Bio!
Neuro-Bio is delighted to welcome Nathalia Mayag Medina as part of the team. Nathalia recently graduated in pharmacy at University of Barcelona. The Pharmaceutical Sciences degree is a 5-year programme during which she was able to join two projects. First, a directed...
Neuro-Bio and Clota Varde working together for series C fundraising.
Neuro-Bio is delighted to announce that Clota Varde will be supporting its Series C 10 M fundraise. Neuro-Bio and Clota varde team met in December 2022 and have now officially started their collaboration. This is what the Clota Varde team said after visiting...
Neuro-Bio’s CEO talking at the Next Generation Forum 2023.
On Thursday the 19th of January 2023; Neuro-Bio's CEO, Susan Greenfield, talked at the Next Generation Forum 2023. The event was an exciting line-up of promising young talent, interesting product launches and unusual asset classes. Susan Greenfield explained her...
Children & Families Services Midlothian’s Christmas raffle donates to Neuro-Bio
On Friday the 9th of December, Josie Duffy organised a raffle on behalf of Children & Families Services (Social Work) Midlothian and donated the proceeds to Neuro-Bio. Josie would like to say a big thank you to all her colleagues in this service and staff from...
A personal note from Neuro-Bio CEO, Susan Greenfield
As 2022 draws to a close, it seems a good moment to share with you the progress made over the last 12 months. In the Spring (April 5th) and in the Autumn (Sept 27th) we were delighted to host two events for all those external individuals and organisations who have...
Nadine Kabbani visiting Neuro-Bio
On Wednesday the 7th of December Dr Nadine Kabbani, Associate Professor at the School of Systems Biology of the George Mason University, visited Neuro-Bio's headquarter. She spent the day with the team, discussing current and future projects and data. The day ended at...
Neuro-Bio 2022 publications
Since April 2022 Neuro-Bio has had 4 peer-reviewed articles accepted. We are very proud that Neuro-Bio 2022 publications are all in the TOP 5% of journals as they have Impact Factor equal to or greater than 6. Click here to have more information
Neuro-Bio training day
On Thursday the 8th of December, the whole Neuro-Bio team took part in a team building experience, provided by Heather Bunney from Cegos Swiss. During the training, many interactive activities were completed by team. This helped understanding different personalities...
Neuro-Bio’s CEO opens Aptamer Group’s new state-of-the-art laboratories.
On Friday 28th of November Neuro-Bio's CEO, Susan Greenfield, opens Aptamer Group's new state-of-the-art laboratories and presented on the challenges in scientific discovery. To read the full article, click the link.
Allies of Neuro-Bio
Neuro-Bio has launched a new webpage called "Allies of Neuro-Bio" in which people living with Alzheimer’s Disease and their careers can send their thoughts. Neuro-Bio will only be able to post a limited number and the page will simply be a notice board, not a...
